Human leukocyte antigen haploidentical hematopoietic stem cell transplantation: Indications and tentative outcomes in Japan

Seminars in Hematology

Volumn 42, Issue 2, 2005, Pages 112-118

  Kodera, Yoshihisa ^a   Nishida, Tetsuya ^a   Ichinohe, Tatsuo ^b   Saji, Hiroo ^c  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD34 ANTIGEN; CYCLOSPORIN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADVANCED CANCER; ALLELE; ALLOGENEIC STEM CELL TRANSPLANTATION; BLOOD BANK; BONE MARROW TRANSPLANTATION; CHIMERA; CLINICAL TRIAL; DONOR; DRUG SCREENING; FAMILY; GENE LOCUS; GRAFT SURVIVAL; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOLOGICAL TOLERANCE; JAPAN; LEUKEMIA; OUTCOMES RESEARCH; PATIENT; PRIORITY JOURNAL; PROPHYLAXIS; PURIFICATION; RECIPIENT; RELATIVE; RETROSPECTIVE STUDY; REVIEW; SIBLING; SURVIVAL TIME; T CELL DEPLETION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 17444376823     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.02.001     Document Type: Article

References (33)

1. E.D. Thomas Karnofsky Memorial Lecture Marrow transplantation for malignant disease J Clin Oncol 1 1983 517 531
2. N. Hirabayashin, Y. Kodera, T. Matsuyama, M. Tanimoto, K. Horibe, T. Naoe Bone marrow transplantation in 614 patients Twenty years experience of Nagoya Bone Marrow Transplantation Group (NBMTG) Transplant Proc 27 1995 1380 1382
3. R.I. Storb, E.D. Thomas, C.D. Buckner, R.A. Clift, F.L. Johnson, A. Fefer Allogeneic marrow grafting for treatment of aplastic anemia Blood 43 1974 157 180
4. S. Kojima, T. Matsuyama, Y. Kodera, N. Hirabayashi, Y. Morishima, H. Iwamura Allogeneic bone marrow transplantation in 25 patients with severe aplastic anemia Acta Haematol Jpn 51 1988 705 714
5. N.A. Kernan, G. Bartsch, R.C. Ash, P.G. Beatty, R. Champlin, A. Filipovich Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program N Eng1 J Med 328 1993 592 602
6. Y. Kodera, Y. Morishima, S. Kato, Y. Akiyama, H. Sao, T. Matsuyama Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program Confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia Bone Marrow Transplant 24 1999 995 1003
7. H.J. Deeg, K. Seidel, J. Casper, C. Anasetti, S. Davies, J.L. Gajeweski Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy Biol Blood Marrow Transplant 5 1999 243 252
8. S. Kojima, T. Matsuyama, S. Kato, H. Kigasawa, R. Kobayashi, A. Kikuta Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors The Japan Marrow Donor Program Blood 100 2002 799 803
9. H.E. Broxmyer Human umbilical cord blood is a source of transplantable hematopoietic stem/progenitor cells Proc Natl Acad Sci U S A 86 1989 3828 3832
10. S. Kato, H. Nishihira, K. Hara, K. Kato, T. Takahashi, N. Sato Cord blood transplantation and cord blood bank in Japan Bone Marrow Transplant 25 suppl 2 2000 S68 S70
11. J.A. Hansen, P.G. Beatty, C. Anasetti, R.A. Clift, P.J. Martin, J. Sanders Treatment of leukemia by marrow transplantation from donors other than HLA genotypically identical siblings R.P. Gale R.E. Champlin Progress in Bone Marrow Transplantation 1987 Liss New York, NY 667 676
12. K. Horibe, J. Yoshida, K. Oiwa, Y. Kodera, H. Iwamura, T. Matsuyama Bone marrow transplantation from related donors other than HLA identical siblings in Japanese patients with hematological malignancies Acta Haematol Jpn 53 1990 94 102
13. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma Blood 85 1995 1647 1654
14. + selected cells from an HLA haplo-identical related donor A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood Bone Marrow Transplant 26 2000 1281 1290
15. A. Hiraoka, Y. Ohashi, S. Okamoto, Y. Moriyama, T. Nagao, Y. Kodera Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation Bone Marrow Transplant 28 2001 181 185
16. J.J. van Rood, F.R. Loberiza Jr, M.J. Zhang, M. Oudshoorn, F. Claas, M.S. Cairo Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA haploidentical sibling Blood 99 2002 1572 1577
17. S. Tamaki, T. Ichinohe, K. Matsuo, N. Hamajima, N. Hirabayashi, H. Dohy Japan Society of Hematopoietic Cell Transplantation Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts Bone Marrow Transplant 28 2001 375 380
18. The Japan Society for Hematopoietic Cell Transplantation Office of Nationwide Survey: The Japan Society for Hematopoietic Cell Transplantation. Annual Report of Nationwide Survey 2004 (in Japanese). Nagoya, Japan, 2004
19. Y. Morishima, Y. Kodera, N. Hirabayashi, M. Tanimoto, T. Matsuyama, K. Horibe Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese Bone Marrow Transplant 15 1995 235 239
20. Y. Morishima, Y. Morishita, M. Tanimoto, R. Ohno, H. Saito, K. Horibe Low incidence of acute graft graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings Possible role of genetic homogeneity Blood 74 1989 2252 2256
21. P.G. Beatty, R.A. Clift, E.M. Mickelson, B.B. Nisperos, N. Flournoy, P.J. Martin Marrow transplantation from related donors other than HLA HLA-identical siblings N Engl J Med 313 1985 765 771
22. Y. Kanda, S. Chiba, H. Hirai, H. Sakamaki, T. Iseki, Y. Kodera Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000) Blood 102 2003 1541 1547
23. T. Sasazuki, T. Juji, Y. Morishima, N. Kinukawa, H. Kashiwabara, Y. Kodera Importance of HLA class I allele matching for clinical outcome after unrelated donor hematopoietic stem cell transplantation N Engl J Med 339 1998 1177 1185
24. Y. Morishima, T. Sasazuki, H. Inoko, T. Juji, T. Akaza, K. Yamamoto The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors Blood 99 2002 4200 4206
25. T. Nishida, T. Murayama, H. Hirai, S. Okamoto, H. Sao, M. Hara Phase-2 study of FK506 for GVHD prophylaxis after BMT from HLA DNA typing mismatched unrelated donor Rinshoketsueki 44 2003 678 (in Japanese)
26. T. Ichinohe, E. Maruya, H. Saji Long-term feto-maternal microkimerism Nature's hidden clue for alternative donor hematopoietic cell transplantation Int J Hematol 76 2002 229 237
27. T. Ichinohe, T. Uchiyama, S. Shimazaki, K. Matsuo, S. Tamaki, M. Hino Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microkimerism Blood 104 2004 3821 3828
28. P.G. Beatty, R.A. Clift, E.M. Mickelson, B.B. Nisperos, N. Flournoy, P.J. Martin Marrow transplantation from related donors other than HLA-identical siblings N Engl J Med 313 1985 765 771
29. E.W. Petersdorf, G.M. Longton, C. Anasetti, P.J. Martin, E.M. Mickelson, A.G. Smith The significance of HLA-DRB1 matching on clinical outcome after HLA-A,B, DR identical unrelated donor marrow transplantation Blood 86 1995 1606 1613
30. N. Schmitz, A. Bacigalupo, D. Hasenclever, A. Nagler, E. Gluckman, P. Clark Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia First results of a randomised multicentre trial of European Group for Blood and Marrow Transplantation Bone Marrow Transplant 21 1998 995 1003
31. M. Harada, K. Shinagawa, T. Kawano, M. Kasai, H. Sawada, S. Nakao Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan blood cell transplantation study group Bone Marrow Transplant 21 1998 s54 s56 (suppl 3)
32. E. Gluckman, V. Rocha, W. Arcese, G. Michel, G. Sanz, K.W. Chan Factors associated with outcomes of unrelated cord blood transplant Guidelines for donor choice Exp Hematol 32 2004 397 407
33. H. Nishihira, K. Kato, K. Isoyama, T.A. Takahashi, S. Kai, S. Kato The Japanese Cord Blood Bank Network experience with cord blood transplantation from unrelated donors for haematological malignancies An evaluation of graft-versus-host disease prophylaxis Br J Haematol 120 2003 516 522